These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 12297509)
1. Signaling through Gi family members in platelets. Redundancy and specificity in the regulation of adenylyl cyclase and other effectors. Yang J; Wu J; Jiang H; Mortensen R; Austin S; Manning DR; Woulfe D; Brass LF J Biol Chem; 2002 Nov; 277(48):46035-42. PubMed ID: 12297509 [TBL] [Abstract][Full Text] [Related]
2. Interactions in platelets between G proteins and the agonists that stimulate phospholipase C and inhibit adenylyl cyclase. Brass LF; Woolkalis MJ; Manning DR J Biol Chem; 1988 Apr; 263(11):5348-55. PubMed ID: 2833506 [TBL] [Abstract][Full Text] [Related]
3. Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling. Kim S; Foster C; Lecchi A; Quinton TM; Prosser DM; Jin J; Cattaneo M; Kunapuli SP Blood; 2002 May; 99(10):3629-36. PubMed ID: 11986217 [TBL] [Abstract][Full Text] [Related]
4. P2Y12 ADP receptor-dependent tyrosine phosphorylation of proteins of 27 and 31 kDa in thrombin-stimulated human platelets. Fälker K; Lange D; Presek P Thromb Haemost; 2005 May; 93(5):880-8. PubMed ID: 15886804 [TBL] [Abstract][Full Text] [Related]
6. Activation of Rap1B by G(i) family members in platelets. Woulfe D; Jiang H; Mortensen R; Yang J; Brass LF J Biol Chem; 2002 Jun; 277(26):23382-90. PubMed ID: 11970953 [TBL] [Abstract][Full Text] [Related]
7. A selective role for phosphatidylinositol 3,4,5-trisphosphate in the Gi-dependent activation of platelet Rap1B. Lova P; Paganini S; Hirsch E; Barberis L; Wymann M; Sinigaglia F; Balduini C; Torti M J Biol Chem; 2003 Jan; 278(1):131-8. PubMed ID: 12407113 [TBL] [Abstract][Full Text] [Related]
8. IRS-1 mediates inhibition of Ca2+ mobilization by insulin via the inhibitory G-protein Gi. Ferreira IA; Eybrechts KL; Mocking AI; Kroner C; Akkerman JW J Biol Chem; 2004 Jan; 279(5):3254-64. PubMed ID: 14602724 [TBL] [Abstract][Full Text] [Related]
9. Partial agonist clonidine mediates alpha(2)-AR subtypes specific regulation of cAMP accumulation in adenylyl cyclase II transfected DDT1-MF2 cells. Limon-Boulez I; Bouet-Alard R; Gettys TW; Lanier SM; Maltier JP; Legrand C Mol Pharmacol; 2001 Feb; 59(2):331-8. PubMed ID: 11160870 [TBL] [Abstract][Full Text] [Related]
10. Aberrant adenylyl cyclase/cAMP signal transduction and G protein levels in platelets from hypertensive patients improve with antihypertensive drug therapy. Marcil J; Schiffrin EL; Anand-Srivastava MB Hypertension; 1996 Jul; 28(1):83-90. PubMed ID: 8675269 [TBL] [Abstract][Full Text] [Related]
11. Lipid rafts are required in Galpha(i) signaling downstream of the P2Y12 receptor during ADP-mediated platelet activation. Quinton TM; Kim S; Jin J; Kunapuli SP J Thromb Haemost; 2005 May; 3(5):1036-41. PubMed ID: 15869601 [TBL] [Abstract][Full Text] [Related]
12. Characterization of adenylyl cyclases in cultured human granulosa cells. Asbóth G; Price SA; Bellinger J; Ledger W; Barlow DH; Bernal AL Reproduction; 2001 Feb; 121(2):217-28. PubMed ID: 11226046 [TBL] [Abstract][Full Text] [Related]
13. Nitric oxide attenuates alpha(2)-adrenergic receptors by ADP-ribosylation of G(i)alpha in ciliary epithelium. Moroi SE; Hao Y; Sitaramayya A Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2056-62. PubMed ID: 11481272 [TBL] [Abstract][Full Text] [Related]
14. Constitutive G(i2)-dependent activation of adenylyl cyclase type II by the 5-HT1A receptor. Inhibition by anxiolytic partial agonists. Albert PR; Sajedi N; Lemonde S; Ghahremani MH J Biol Chem; 1999 Dec; 274(50):35469-74. PubMed ID: 10585418 [TBL] [Abstract][Full Text] [Related]
15. A Gi-dependent pathway is required for activation of the small GTPase Rap1B in human platelets. Lova P; Paganini S; Sinigaglia F; Balduini C; Torti M J Biol Chem; 2002 Apr; 277(14):12009-15. PubMed ID: 11815620 [TBL] [Abstract][Full Text] [Related]
16. The bioactive phospholipid, lysophosphatidylcholine, induces cellular effects via G-protein-dependent activation of adenylyl cyclase. Yuan Y; Schoenwaelder SM; Salem HH; Jackson SP J Biol Chem; 1996 Oct; 271(43):27090-8. PubMed ID: 8900200 [TBL] [Abstract][Full Text] [Related]
17. Differential regulation of type I and type VIII Ca2+-stimulated adenylyl cyclases by Gi-coupled receptors in vivo. Nielsen MD; Chan GC; Poser SW; Storm DR J Biol Chem; 1996 Dec; 271(52):33308-16. PubMed ID: 8969190 [TBL] [Abstract][Full Text] [Related]
18. Regulators of platelet cAMP levels: clinical and therapeutic implications. Noé L; Peeters K; Izzi B; Van Geet C; Freson K Curr Med Chem; 2010; 17(26):2897-905. PubMed ID: 20858171 [TBL] [Abstract][Full Text] [Related]
19. Coordinated signaling through both G12/13 and G(i) pathways is sufficient to activate GPIIb/IIIa in human platelets. Dorsam RT; Kim S; Jin J; Kunapuli SP J Biol Chem; 2002 Dec; 277(49):47588-95. PubMed ID: 12297512 [TBL] [Abstract][Full Text] [Related]
20. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor. Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]